PNC Financial Services Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-512
| Closed | -$548 | – | 4803 |
|
|
2023
Q3 | $548 | Sell |
512
-378
| -42% | -$405 | ﹤0.01% | 4449 |
|
|
2023
Q2 | $2.31K | Buy |
890
+576
| +183% | +$1.49K | ﹤0.01% | 4341 |
|
|
2023
Q1 | $1.28K | Buy |
314
+48
| +18% | +$196 | ﹤0.01% | 4398 |
|
|
2022
Q4 | $1.34K | Buy |
266
+174
| +189% | +$874 | ﹤0.01% | 4351 |
|
|
2022
Q3 | $2K | Hold |
92
| – | – | ﹤0.01% | 4228 |
|
|
2022
Q2 | $2K | Hold |
92
| – | – | ﹤0.01% | 4258 |
|
|
2022
Q1 | $2K | Hold |
92
| – | – | ﹤0.01% | 4247 |
|
|
2021
Q4 | $2K | Hold |
92
| – | – | ﹤0.01% | 4207 |
|
|
2021
Q3 | $2K | Hold |
92
| – | – | ﹤0.01% | 4154 |
|
|
2021
Q2 | $2K | Hold |
92
| – | – | ﹤0.01% | 4066 |
|
|
2021
Q1 | $2K | Buy |
+92
| New | +$2K | ﹤0.01% | 3983 |
|